Search PubMed⌕ Search

Biomedical subjects

M R Wallace

Publications and source records attributed to M R Wallace.

At least 181 records · Page 10Linked to original sources

Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis.

In the last several years, five human plasma prealbumin (transthyretin) variants have been discovered in association with hereditary amyloidosis, a late-onset fatal disorder. We recently studied a patient of German descent with peripheral neuropathy and bowel dysfunction. Biopsied rectal tissue contained amyloid that stained with anti-human prealbumin. Amino acid sequence analysis of the patient's plasma prealbumin revealed both normal and variant prealbumin molecules, with the variant containing a tyrosine at position 77 instead of serine. We predicted a single nucleotide change in codon 77 of the variant prealbumin gene, which we then detected in the patient's DNA using the restriction enzyme SspI and a specifically tailored genomic prealbumin probe. DNA tests of other family members identified several gene carriers. This is the sixth prealbumin variant implicated in amyloidosis, and adds to the accumulating evidence that the prealbumin amyloidoses are more varied and prevalent than previously thought.

Amyloidosis↗

A DNA test for Indiana/Swiss hereditary amyloidosis (FAP II).

Autosomal dominant amyloidosis of the Indiana/Swiss type is a late-onset disorder characterized by carpal tunnel syndrome, progressive peripheral neuropathy, vitreous deposits, and cardiomyopathy. This disorder was originally described in a large Indiana family of Swiss descent and is also known as familial amyloidotic polyneuropathy (FAP) type II. In the Indiana family, the genetic basis of the disease is a variant of plasma prealbumin (transthyretin), which has a serine-for-isoleucine substitution at amino acid 84 of the 127-residue prealbumin molecule. We predicted that the corresponding mutation in the prealbumin gene consisted of a T-to-G change in codon 84 (which created an AluI recognition site) and then demonstrated the extra AluI site in the DNA of patients by Southern blot analysis with a genomic prealbumin probe. This verifies the protein findings at the DNA level and provides a direct, reliable DNA test for the Ser-84 prealbumin gene associated with Indiana/Swiss hereditary amyloidosis.

Amyloidosis↗

Headache angina.

Explore the source record for details and available documents.

Adult↗

Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Appalachian amyloid.

A family with hereditary amyloidosis characterized by peripheral neuropathy and cardiomyopathy is described. Lack of eye involvement sets their disease apart from the Indiana/Swiss familial amyloidotic polyneuropathy type II. The disease is of late onset; affected members die of cardiomyopathy after age 60. The late onset and lack of clinically significant neuropathy in several family members has led to misdiagnosis of the cardiomyopathy. Immunohistochemistry using antiprealbumin antiserum showed staining of amyloid deposits in nerve and heart.

Adult↗

Molecular detection of carriers of hereditary amyloidosis in a Swedish-American family.

Autosomal dominant amyloidosis, also known as familial amyloidotic polyneuropathy (FAP), is a late-onset disorder associated with variants of the protein prealbumin. In FAP Type I, the variant contains a single amino acid substitution at position 30 in the subunit. This substitution corresponds to a single base change in the gene, coincidentally creating a new site for the restriction enzyme NsiI. This change is detectable in the DNA of gene carriers with restriction fragment length polymorphism (RFLP) methods. A well-characterized American family of Swedish origin was studied by this method using a prealbumin cDNA. The RFLP data were found to correlate with previous biochemical characterization of the prealbumin in this family, indicating that this test represents a reliable way to directly detect the DNA mutation responsible for the condition. This test can be used for preclinical diagnosis of gene carriers, including prenatal diagnosis.

Amyloidosis↗

Studies of a DNA marker (G8) genetically linked to Huntington disease in British families.

Close genetic linkage has been shown between the DNA sequence G8 (locus D4S10) and 16 British families with Huntington disease using the HindIII, EcoR1, Nci1, and Pst1 polymorphisms detected by G8, and by combining all the polymorphisms to give a combined haplotype. Two recombinants have been detected in these families giving a maximum lod score of 17.60 at a theta of 0.02. These results confirm the originally reported linkage between the loci and provide evidence against significant multilocus heterogeneity for Huntington disease.

Alleles↗

Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis.

Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant late-onset disorder characterized by the extracellular deposition of amyloid fibrils. In all cases studied these fibrils have been found to be composed of plasma prealbumin (transthyretin) containing a single amino acid substitution. Biochemical studies were conducted on amyloid from one patient and plasma prealbumin from his affected brother, both part of a large kindred from the Appalachian region of the United States. Sequence analysis of the amyloid subunit protein showed it to be prealbumin with about two-thirds of the molecules containing a substitution of alanine for threonine at position 60. Studies of the plasma prealbumin showed that the same substitution was present in 40-45% of the protein. Based on this substitution and the prealbumin cDNA sequence, a Pvu II restriction fragment length DNA polymorphism (RFLP) was predicted and demonstrated in DNA of both patients as well as other family members. This RFLP confirms the predicted DNA mutation responsible for the protein variant, and represents an accurate method for detection of this gene.

Aged↗

Localization of the human prealbumin gene to chromosome 18.

A human liver cDNA library was screened using an oligonucleotide probe based on the amino acid sequence of human prealbumin. The cDNA insert of one positive clone was sequenced and found to contain the entire coding sequence of human prealbumin plus untranslated 5' and 3' regions. This cDNA was used to probe DNA from a panel of mouse/human somatic cell hybrids. Only those hybrids containing human chromosome 18 showed the human-specific hybridization pattern, thereby localizing the human prealbumin gene to this chromosome.

Amino Acid Sequence↗

DNA markers for nervous system diseases.

Recombinant DNA technology has provided a vast new source of DNA markers displaying heritable sequence variation in humans. These markers can be used in family studies to identify the chromosomal location of defective genes causing nervous system disorders. The discovery of a DNA marker linked to Huntington's disease has opened new avenues of research into this disorder and may ultimately permit cloning and characterization of the defective gene.

Alleles↗

Huntington disease: estimation of heterozygote status using linked genetic markers.

The recent finding of a closely linked DNA marker to the Huntington Disease gene allows the opportunity for prenatal and preclinical diagnosis. The methodology for using these markers for prediction in late age of onset disorders is discussed. Since these methods are both difficult and complex for the majority of genetic counselors, a simple solution is suggested. This involves using the well known linkage program LIPED and running it twice for a given consultand, once assuming he carries the gene and once that he is homozygous normal. This will allow accurate predictions for counselors with limited backgrounds in pedigree analysis.

Biometry↗

Hemorrhagic diathesis in multiple myeloma.

Hemorrhage occurs during the clinical course in 15% of patients with multiple myeloma. We recently treated a patient with myeloma who had postoperative bleeding and hematuria despite normal coagulation parameters and platelet count. Platelet function studies revealed markedly abnormal aggregation to all stimulants. Plasma exchange successfully reversed in vitro and in vivo bleeding abnormalities.

Blood Platelet Disorders↗

Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn.

In 25 patients on maintenance haemodialysis the mean predialysis plasma aluminium level fell on two occasions when oral aluminium hydroxide was withdrawn for seven and twelve weeks. Substitution of half the prescribed dose of aluminium hydroxide with magnesium hydroxide led to a significant lowering of predialysis plasma aluminium levels over seven months, with no change in plasma phosphate levels. Oral magnesium hydroxide was associated with a mild rise in plasma magnesium levels.

Administration, Oral↗

Serial serum immunoglobulin levels in acute postinfectious glomerulonephritis.

In 102 children with acute postinfectious glomerulonephritis, serum immunoglobulin levels at six month follow-up were significantly lower than those on admission to hospital. For those with a normal C 3 level on admission, the admission level of IgG was lower than for the group as a whole, while serum IgA and IgM levels on admission were no different from the group as a whole. Absolute levels of serum immunoglobulin in acute glomerulonephritis will not differentiate one kind of renal lesion from another.

Acute Disease↗

Acute glomerulonephritis in childhood: a prospective study of hospital admissions.

Eighty-four children with acute post-infectious glomerulonephritis were admitted to the Waikato Hospital in 1976-1980. The rate of admission, sex difference, and seasonal variation in admission numbers were similar to the pattern of the previous ten years. Only 11 children (13 percent) showed evidence of antecedent streptococcal infection, but there was evidence for a variety of other infections before admission. Clinical abnormalities had disappeared in the majority of 31 children reviewed at 48 months, although 20 percent had proteinuria. The long-term prognosis is yet to be determined for these children.

Acute Disease↗